N@N

BXC, AIS, SENO, DISK, ROIA Expected To Be Lower Leading Up To Next Earnings Releases

^{Published on 2009-07-29 10:30:41, Last Modified on 2010-12-22 14:38:28 - WOPRAI}
 

July 30, 2009 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed before their last 12 quarterly, 6 quarterly and July/August earnings reports. BlueLinx Holdings (NYSE: BXC), Antares Pharma (AMEX: AIS), SenoRX (NASDAQ: SENO), Image Entertainment (NASDAQ: DISK) and Radio One (NASDAQ: ROIA) are all expected to be lower leading up to their next earnings release. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act before its earnings are released. The specific technology used to make these predictions is available for a low monthly fee at http://www.squeezetrigger.com/services/strat/mh.php . The following stocks are expected to go lower leading up to their next earnings release:

Symbol Company # of Reports Quarter Release Date

BXC BlueLinx Holdings Inc. 12 quarters Q2 8/6/2009

AIS Antares Pharma Inc. August earnings Q2 8/12/2009

SENO SenoRx Inc. 12 quarters Q2 8/3/2009

DISK Image Entertainment 12 quarters Q1 8/13/2009

ROIA Radio One, Inc. 12 quarters Q2 8/5/2009

Earnings, or profits, drive stock prices. The market values a company based on its current and anticipated future ability to make money. The market takes the earnings pulse of a company four times per year when quarterly reports are issued. When this information is released it can often be a trend-changing or a trend confirming event because the information is so vital to the market's perception of the vitality of that company.

This technology is designed to help the stock trader identify those companies that seem to have a consistent pattern of movement before or after the earnings release date, based on the history of earnings releases for that company. It combines a calendar of expected earnings releases with a history of past earnings releases in a way that lets you see if a pattern exists.

BlueLinx Holdings, Inc. (NYSE: BXC) through its subsidiary, BlueLinx Corporation, distributes building products in the United States. It distributes products in two principal categories: structural products and specialty products. Structural products include plywood, oriented strand board, rebar and remesh, lumber, and other wood products primarily used for structural support, walls, and flooring in construction projects. Specialty products include roofing, insulation, specialty panels, moulding, engineered wood products, vinyl products (used primarily in siding), composite decking, and metal products (excluding rebar and remesh). The companya�s customers include building materials dealers, industrial users of building products, manufactured housing builders, and home improvement centers. It sells its products through three distribution channels: warehouse sales, reload sales, and direct sales. The company was founded in 1996 and is headquartered in Atlanta, Georgia.

Antares Pharma, Inc. (AMEX: AIS) operates as a specialty drug delivery/pharmaceutical company. Its drug delivery platforms include Advanced Transdermal Delivery gels, disposable pressure assisted auto injection systems, reusable needle-free injection systems, disposable pen injection systems, and oral disintegrating tablets. The companya�s transdermal systems consist of semisolid dosage forms, which deliver medication and minimize gastrointestinal impact, as well as the initial liver metabolism effect of orally ingested drugs. Its injection device platform offers reusable needle-free injectors, which deliver precise medication doses through pressurized liquid penetration of the skin without a needle; disposable pressure assisted auto injectors that provide subcutaneous injections with minimal discomfort and safety of a shielded needle; and disposable pen injectors, which are needle-based devices designed to deliver multiple injections from multi-dose drug cartridges. In addition, the companya�s oral disintegrating tablets are designed to help patients experiencing difficulty in swallowing pills, tablets, or capsules. Antares Pharma sells its products through pharmaceutical and medical device companies primarily in the United States and Europe. It has collaborative arrangements and license agreements with BioSante Pharmaceuticals, Inc.; Jazz Pharmaceuticals; Population Council; Ferring Pharmaceuticals BV; Teva Pharmaceutical Industries, Ltd.; Eli Lilly and Company; JCR Pharmaceuticals Co., Ltd.; and Solvay Pharmaceuticals BV. The company was formerly known as Medi-Ject Corporation and changed its name to Antares Pharma, Inc. in January 2001. Antares Pharma, Inc. was founded in 1979 and is headquartered in Ewing, New Jersey.

SenoRx, Inc. (NASDAQ: SENO), a medical device company, develops, manufactures, and sells devices for the diagnosis and treatment of breast cancer. The company offers diagnostic products, including breast biopsy systems, and location and lymph node gamma ray detection devices; and marking products comprising tissue markers, which identify the biopsy site for future diagnostic and surgical reference. It also provides excising products, which is a tissue cutting devices designed to facilitate the contoured removal of lesions and facilitate the use of balloons in radiation therapy; and treatment products, including radiation balloons for localized partial breast radiation therapy. The companya�s breast biopsy systems include SenoRx Breast Biopsy Console, EnCor, EnCor 360(3), VisiLoc, SenoSonix, and SenoSonix Handcarry; tissue markers and location devices comprise Gel Mark, Gel Mark Ultra, Gel Mark UltraCor, SenoMark, Gel Mark UltraCor MRI, Tissue Marker Line Extension, Starch Mark, and Loc Wire Replacement; and gamma ray detection devices consist of Gamma Finder. Its excision and reconstruction products include SenoPulse RF Generator and Single Step; and radiation therapy products comprise Contura MLB, Contura Shape Select MLB, and CED Device. SenoRx, Inc. markets its products through direct sales force and distributors in the United States and internationally. The company was formerly known as BiopSolation Medical, Inc. and changed its name to SenoRx, Inc. SenoRx, Inc. was founded in 1998 and is headquartered in Irvine, California.

Image Entertainment, Inc. (NASDAQ: DISK) engages in the acquisition, production, and distribution of entertainment programming in North America. It releases its library of exclusive content on various formats and platforms, including digital versatile disc, Blu-ray Disc, digital, broadcast television, cable, satellite, theatrical, and non-theatrical exploitation. The company offers an array of general and specialty content comprising feature films, comedy, music concerts, urban, theatre, documentaries, theatrical catalogue films, independent films, foreign films, youth culture/lifestyle, television, and gospel. As of March 31, 2009, it had approximately 3,200 DVD titles and 340 CD titles, as well as holds digital rights to approximately 2,000 video programs and approximately 300 audio titles containing approximately 5,100 individual tracks. The company also acquires rights to audio content for distribution via digital platforms and on CD in various genres and configurations, including albums, compilation CDs, stand-up comedy programs, broadway original cast recordings, and audio recordings from live concert event DVDs. Image Entertainment, Inc. sells its products to traditional retailers, specialty retailers, rental customers, Internet retailers, and wholesale distributors, as well as through alternative distribution, such as direct-to-consumer print catalogs, direct response campaigns, subscription service/club sales, home shopping television channels, other non-traditional sales channels, kiosks, and sub-distributors. The company was formerly known as Key International Film Distributors, Inc. and changed its name to Image Entertainment, Inc. in 1983. Image Entertainment, Inc. was founded in 1975 and is headquartered in Chatsworth, California.

Radio One, Inc. (NASDAQ: ROIA) (www.radio-one.com) is one of the nation's largest radio broadcasting companies and the largest radio broadcasting company that primarily targets African-American and urban listeners. Radio One currently owns 53 broadcast stations located in 16 urban markets in the United States. Additionally, Radio One owns Interactive One (www.interactiveone.com), an online platform serving the African-American community through social content, news, information, and entertainment, which operates a number of branded sites, including News One, UrbanDaily, HelloBeautiful, and Magazine One, Inc. (d/b/a Giant Magazine) (www.giantmag.com), interests in TV One, LLC (www.tvoneonline.com), a cable/satellite network programming primarily to African-Americans, Reach Media, Inc. (www.blackamericaweb.com), owner of the Tom Joyner Morning Show and other businesses associated with Tom Joyner, and Community Connect Inc. (www.communityconnect.com), an online social networking company, which operates a number of branded websites, including BlackPlanet, MiGente, and Asian Avenue.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

One example from the SqueezeTrigger database is approximately 2.5 billion short sale transactions going back to January 1, 2005, and SqueezeTrigger calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data. Total Short Interest is the number of shares shorted but not yet covered, and is different from total short volume. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.squeezetrigger.com

Go to www.SqueezeTrigger.com to find out the exact price that the entire Total Short Interest will start covering!

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha�s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641